Skip to main content
Top
Published in: Calcified Tissue International 6/2014

01-06-2014 | Original Research

Hepcidin1 Knockout Mice Display Defects in Bone Microarchitecture and Changes of Bone Formation Markers

Authors: Guang Si Shen, Qing Yang, Jing Long Jian, Guo Yang Zhao, Lu Lin Liu, Xiao Wang, Wen Zhang, Xi Huang, You Jia Xu

Published in: Calcified Tissue International | Issue 6/2014

Login to get access

Abstract

Iron accumulation is a risk factor of osteoporosis; mechanisms leading to iron-related bone loss are not fully determined. We sought to better understand the effect of chronic iron accumulation on bone over the life span in a mouse model. Hepcidin1 knockout (Hepc1 −/−) male mice and their littermate control wild type (WT) mice at 7 months old were used in this study. Serum iron and ferritin as well as iron contents in liver and femur were significantly increased in Hepc1 −/− mice compared to WT mice. We found that Hepc1 −/− mice had a phenotype of low bone mass and alteration of the bone microarchitecture, most likely caused by a decreased osteoblastic activity. Cell culture studies indicated that chronic iron accumulation decreased bone formation, probably by affecting bone morphogenetic protein signaling.
Appendix
Available only for authorised users
Literature
1.
go back to reference MacKenzie EL, Iwasaki K, Tsuji Y (2008) Intracellular iron transport and storage: from molecular mechanisms to health implications. Antioxid Redox Signal 10:997–1030PubMedCentralPubMedCrossRef MacKenzie EL, Iwasaki K, Tsuji Y (2008) Intracellular iron transport and storage: from molecular mechanisms to health implications. Antioxid Redox Signal 10:997–1030PubMedCentralPubMedCrossRef
2.
go back to reference Jian J, Pelle E, Huang X (2009) Iron and menopause: does increased iron affect the health of postmenopausal women? Antioxid Redox Signal 11:2939–2943PubMedCentralPubMedCrossRef Jian J, Pelle E, Huang X (2009) Iron and menopause: does increased iron affect the health of postmenopausal women? Antioxid Redox Signal 11:2939–2943PubMedCentralPubMedCrossRef
3.
go back to reference Huang X, Xu Y, Partridge NC (2013) Dancing with sex hormones, could iron contribute to the gender difference in osteoporosis? Bone 55:458–460PubMedCrossRef Huang X, Xu Y, Partridge NC (2013) Dancing with sex hormones, could iron contribute to the gender difference in osteoporosis? Bone 55:458–460PubMedCrossRef
4.
go back to reference Li GF, Pan YZ, Sirois P, Li K, Xu YJ (2012) Iron homeostasis in osteoporosis and its clinical implications. Osteoporos Int 23:2403–2408PubMedCrossRef Li GF, Pan YZ, Sirois P, Li K, Xu YJ (2012) Iron homeostasis in osteoporosis and its clinical implications. Osteoporos Int 23:2403–2408PubMedCrossRef
6.
go back to reference Weinberg ED (2008) Role of iron in osteoporosis. Pediatr Endocrinol Rev 6:81–85PubMed Weinberg ED (2008) Role of iron in osteoporosis. Pediatr Endocrinol Rev 6:81–85PubMed
7.
go back to reference Ebrahimpour L, Akhlaghpoor S, Azarkayvan A, Salehi M, Morteza A, Alinaghi R (2012) Correlation between bone mineral densitometry and liver/heart iron overload evaluated by quantitative T2* MRI. Hematology 17:297–301PubMedCrossRef Ebrahimpour L, Akhlaghpoor S, Azarkayvan A, Salehi M, Morteza A, Alinaghi R (2012) Correlation between bone mineral densitometry and liver/heart iron overload evaluated by quantitative T2* MRI. Hematology 17:297–301PubMedCrossRef
8.
go back to reference Guggenbuhl P, Brissot P, Loreal O (2011) Haemochromatosis: the bone and the joint. Best Pract Res Clin Rheumatol 25:649–664PubMedCrossRef Guggenbuhl P, Brissot P, Loreal O (2011) Haemochromatosis: the bone and the joint. Best Pract Res Clin Rheumatol 25:649–664PubMedCrossRef
9.
go back to reference Schnitzler CM, Macphail AP, Shires R, Schnaid E, Mesquita JM, Robson HJ (1994) Osteoporosis in African hemosiderosis: role of alcohol and iron. J Bone Miner Res 9:1865–1873PubMedCrossRef Schnitzler CM, Macphail AP, Shires R, Schnaid E, Mesquita JM, Robson HJ (1994) Osteoporosis in African hemosiderosis: role of alcohol and iron. J Bone Miner Res 9:1865–1873PubMedCrossRef
10.
11.
go back to reference Arlet JB, Courbebaisse M, Chatellier G, Eladari D, Souberbielle JC, Friedlander G, de Montalembert M, Prie D, Pouchot J, Ribeil JA (2013) Relationship between vitamin D deficiency and bone fragility in sickle cell disease: a cohort study of 56 adults. Bone 52:206–211PubMedCrossRef Arlet JB, Courbebaisse M, Chatellier G, Eladari D, Souberbielle JC, Friedlander G, de Montalembert M, Prie D, Pouchot J, Ribeil JA (2013) Relationship between vitamin D deficiency and bone fragility in sickle cell disease: a cohort study of 56 adults. Bone 52:206–211PubMedCrossRef
12.
go back to reference Kim BJ, Ahn SH, Bae SJ, Kim EH, Lee SH, Kim HK, Choe JW, Koh JM, Kim GS (2012) Iron overload accelerates bone loss in healthy postmenopausal women and middle-aged men: a 3-year retrospective longitudinal study. J Bone Miner Res 27:2279–2290PubMedCrossRef Kim BJ, Ahn SH, Bae SJ, Kim EH, Lee SH, Kim HK, Choe JW, Koh JM, Kim GS (2012) Iron overload accelerates bone loss in healthy postmenopausal women and middle-aged men: a 3-year retrospective longitudinal study. J Bone Miner Res 27:2279–2290PubMedCrossRef
13.
go back to reference Huang X (2010) Treatment of osteoporosis in peri- and post-menopausal women with hepcidin. United States Patent Application US20100204122 A20100204121 Huang X (2010) Treatment of osteoporosis in peri- and post-menopausal women with hepcidin. United States Patent Application US20100204122 A20100204121
14.
go back to reference Tsay J, Yang Z, Ross FP, Cunningham-Rundles S, Lin H, Coleman R, Mayer-Kuckuk P, Doty SB, Grady RW, Giardina PJ, Boskey AL, Vogiatzi MG (2010) Bone loss caused by iron overload in a murine model: importance of oxidative stress. Blood 116:2582–2589PubMedCentralPubMedCrossRef Tsay J, Yang Z, Ross FP, Cunningham-Rundles S, Lin H, Coleman R, Mayer-Kuckuk P, Doty SB, Grady RW, Giardina PJ, Boskey AL, Vogiatzi MG (2010) Bone loss caused by iron overload in a murine model: importance of oxidative stress. Blood 116:2582–2589PubMedCentralPubMedCrossRef
15.
go back to reference De Vernejoul MC, Pointillart A, Golenzer CC, Morieux C, Bielakoff J, Modrowski D, Miravet L (1984) Effects of iron overload on bone remodeling in pigs. Am J Pathol 116:377–384PubMedCentralPubMed De Vernejoul MC, Pointillart A, Golenzer CC, Morieux C, Bielakoff J, Modrowski D, Miravet L (1984) Effects of iron overload on bone remodeling in pigs. Am J Pathol 116:377–384PubMedCentralPubMed
16.
go back to reference Liu G, Men P, Kenner GH, Miller SC (2008) Therapeutic effects of an oral chelator targeting skeletal tissue damage in experimental postmenopausal osteoporosis in rats. Hemoglobin 32:181–190PubMedCrossRef Liu G, Men P, Kenner GH, Miller SC (2008) Therapeutic effects of an oral chelator targeting skeletal tissue damage in experimental postmenopausal osteoporosis in rats. Hemoglobin 32:181–190PubMedCrossRef
17.
go back to reference Guggenbuhl P, Fergelot P, Doyard M, Libouban H, Roth MP, Gallois Y, Chales G, Loreal O, Chappard D (2011) Bone status in a mouse model of genetic hemochromatosis. Osteoporos Int 22:2313–2319PubMedCrossRef Guggenbuhl P, Fergelot P, Doyard M, Libouban H, Roth MP, Gallois Y, Chales G, Loreal O, Chappard D (2011) Bone status in a mouse model of genetic hemochromatosis. Osteoporos Int 22:2313–2319PubMedCrossRef
18.
go back to reference Zhao GY, Zhao LP, He YF, Li GF, Gao C, Li K, Xu YJ (2012) A comparison of the biological activities of human osteoblast hFOB1.19 between iron excess and iron deficiency. Biol Trace Elem Res 150:487–495PubMedCrossRef Zhao GY, Zhao LP, He YF, Li GF, Gao C, Li K, Xu YJ (2012) A comparison of the biological activities of human osteoblast hFOB1.19 between iron excess and iron deficiency. Biol Trace Elem Res 150:487–495PubMedCrossRef
19.
go back to reference Zarjou A, Jeney V, Arosio P, Poli M, Zavaczki E, Balla G, Balla J (2010) Ferritin ferroxidase activity: a potent inhibitor of osteogenesis. J Bone Miner Res 25:164–172PubMedCrossRef Zarjou A, Jeney V, Arosio P, Poli M, Zavaczki E, Balla G, Balla J (2010) Ferritin ferroxidase activity: a potent inhibitor of osteogenesis. J Bone Miner Res 25:164–172PubMedCrossRef
20.
go back to reference Yang Q, Jian J, Abramson SB, Huang X (2011) Inhibitory effects of iron on bone morphogenetic protein 2-induced osteoblastogenesis. J Bone Miner Res 26:1188–1196PubMedCrossRef Yang Q, Jian J, Abramson SB, Huang X (2011) Inhibitory effects of iron on bone morphogenetic protein 2-induced osteoblastogenesis. J Bone Miner Res 26:1188–1196PubMedCrossRef
21.
go back to reference He YF, Ma Y, Gao C, Zhao GY, Zhang LL, Li GF, Pan YZ, Li K, Xu YJ (2013) Iron overload inhibits osteoblast biological activity through oxidative stress. Biol Trace Elem Res 152:292–296PubMedCrossRef He YF, Ma Y, Gao C, Zhao GY, Zhang LL, Li GF, Pan YZ, Li K, Xu YJ (2013) Iron overload inhibits osteoblast biological activity through oxidative stress. Biol Trace Elem Res 152:292–296PubMedCrossRef
23.
go back to reference Lesbordes-Brion JC, Viatte L, Bennoun M, Lou DQ, Ramey G, Houbron C, Hamard G, Kahn A, Vaulont S (2006) Targeted disruption of the hepcidin 1 gene results in severe hemochromatosis. Blood 108:1402–1405PubMedCrossRef Lesbordes-Brion JC, Viatte L, Bennoun M, Lou DQ, Ramey G, Houbron C, Hamard G, Kahn A, Vaulont S (2006) Targeted disruption of the hepcidin 1 gene results in severe hemochromatosis. Blood 108:1402–1405PubMedCrossRef
24.
go back to reference Laftah AH, Ramesh B, Simpson RJ, Solanky N, Bahram S, Schumann K, Debnam ES, Srai SK (2004) Effect of hepcidin on intestinal iron absorption in mice. Blood 103:3940–3944PubMedCrossRef Laftah AH, Ramesh B, Simpson RJ, Solanky N, Bahram S, Schumann K, Debnam ES, Srai SK (2004) Effect of hepcidin on intestinal iron absorption in mice. Blood 103:3940–3944PubMedCrossRef
25.
go back to reference Ganz T (2003) Hepcidin, a key regulator of iron metabolism and mediator of anemia of inflammation. Blood 102:783–788PubMedCrossRef Ganz T (2003) Hepcidin, a key regulator of iron metabolism and mediator of anemia of inflammation. Blood 102:783–788PubMedCrossRef
26.
go back to reference Nemeth E, Tuttle MS, Powelson J, Vaughn MB, Donovan A, Ward DM, Ganz T, Kaplan J (2004) Hepcidin regulates cellular iron efflux by binding to ferroportin and inducing its internalization. Science 306:2090–2093PubMedCrossRef Nemeth E, Tuttle MS, Powelson J, Vaughn MB, Donovan A, Ward DM, Ganz T, Kaplan J (2004) Hepcidin regulates cellular iron efflux by binding to ferroportin and inducing its internalization. Science 306:2090–2093PubMedCrossRef
27.
go back to reference Masaratana P, Patel N, Latunde-Dada GO, Vaulont S, Simpson RJ, McKie AT (2013) Regulation of iron metabolism in Hamp(−/−) mice in response to iron-deficient diet. Eur J Nutr 52:135–143PubMedCrossRef Masaratana P, Patel N, Latunde-Dada GO, Vaulont S, Simpson RJ, McKie AT (2013) Regulation of iron metabolism in Hamp(−/−) mice in response to iron-deficient diet. Eur J Nutr 52:135–143PubMedCrossRef
28.
go back to reference Nicolas G, Bennoun M, Porteu A, Mativet S, Beaumont C, Grandchamp B, Sirito M, Sawadogo M, Kahn A, Vaulont S (2002) Severe iron deficiency anemia in transgenic mice expressing liver hepcidin. Proc Natl Acad Sci USA 99:4596–4601PubMedCentralPubMedCrossRef Nicolas G, Bennoun M, Porteu A, Mativet S, Beaumont C, Grandchamp B, Sirito M, Sawadogo M, Kahn A, Vaulont S (2002) Severe iron deficiency anemia in transgenic mice expressing liver hepcidin. Proc Natl Acad Sci USA 99:4596–4601PubMedCentralPubMedCrossRef
29.
go back to reference Ilyin G, Courselaud B, Troadec MB, Pigeon C, Alizadeh M, Leroyer P, Brissot P, Loreal O (2003) Comparative analysis of mouse hepcidin 1 and 2 genes: evidence for different patterns of expression and co-inducibility during iron overload. FEBS Lett 542:22–26PubMedCrossRef Ilyin G, Courselaud B, Troadec MB, Pigeon C, Alizadeh M, Leroyer P, Brissot P, Loreal O (2003) Comparative analysis of mouse hepcidin 1 and 2 genes: evidence for different patterns of expression and co-inducibility during iron overload. FEBS Lett 542:22–26PubMedCrossRef
30.
go back to reference Ebisawa T, Tada K, Kitajima I, Tojo K, Sampath TK, Kawabata M, Miyazono K, Imamura T (1999) Characterization of bone morphogenetic protein-6 signaling pathways in osteoblast differentiation. J Cell Sci 112(Pt 20):3519–3527PubMed Ebisawa T, Tada K, Kitajima I, Tojo K, Sampath TK, Kawabata M, Miyazono K, Imamura T (1999) Characterization of bone morphogenetic protein-6 signaling pathways in osteoblast differentiation. J Cell Sci 112(Pt 20):3519–3527PubMed
31.
go back to reference Jia P, Xu YJ, Zhang ZL, Li K, Li B, Zhang W, Yang H (2012) Ferric ion could facilitate osteoclast differentiation and bone resorption through the production of reactive oxygen species. J Orthop Res 30:1843–1852PubMedCrossRef Jia P, Xu YJ, Zhang ZL, Li K, Li B, Zhang W, Yang H (2012) Ferric ion could facilitate osteoclast differentiation and bone resorption through the production of reactive oxygen species. J Orthop Res 30:1843–1852PubMedCrossRef
32.
go back to reference Barry M, Sherlock S (1971) Measurement of liver-iron concentration in needle-biopsy specimens. Lancet 1(7690):100–103PubMedCrossRef Barry M, Sherlock S (1971) Measurement of liver-iron concentration in needle-biopsy specimens. Lancet 1(7690):100–103PubMedCrossRef
33.
go back to reference Hall AP, Davies W, Stamp K, Clamp I, Bigley A (2013) Comparison of computerized image analysis with traditional semiquantitative scoring of Perls’ Prussian Blue stained hepatic iron deposition. Toxicol Pathol 41:992–1000PubMedCrossRef Hall AP, Davies W, Stamp K, Clamp I, Bigley A (2013) Comparison of computerized image analysis with traditional semiquantitative scoring of Perls’ Prussian Blue stained hepatic iron deposition. Toxicol Pathol 41:992–1000PubMedCrossRef
34.
go back to reference Isomura H, Fujie K, Shibata K, Inoue N, Iizuka T, Takebe G, Takahashi K, Nishihira J, Izumi H, Sakamoto W (2004) Bone metabolism and oxidative stress in postmenopausal rats with iron overload. Toxicology 197:93–100PubMedCrossRef Isomura H, Fujie K, Shibata K, Inoue N, Iizuka T, Takebe G, Takahashi K, Nishihira J, Izumi H, Sakamoto W (2004) Bone metabolism and oxidative stress in postmenopausal rats with iron overload. Toxicology 197:93–100PubMedCrossRef
35.
go back to reference Trinder D, Baker E (2003) Transferrin receptor 2: a new molecule in iron metabolism. Int J Biochem Cell Biol 35:292–296PubMedCrossRef Trinder D, Baker E (2003) Transferrin receptor 2: a new molecule in iron metabolism. Int J Biochem Cell Biol 35:292–296PubMedCrossRef
36.
go back to reference Kim BJ, Seo M, Huh JK, Kwon CH, Kim JT, Sung KC, Kim BS, Kang JH (2011) Associations of plasma homocysteine levels with arterial stiffness in prehypertensive individuals. Clin Exp Hypertens 33:411–417PubMedCrossRef Kim BJ, Seo M, Huh JK, Kwon CH, Kim JT, Sung KC, Kim BS, Kang JH (2011) Associations of plasma homocysteine levels with arterial stiffness in prehypertensive individuals. Clin Exp Hypertens 33:411–417PubMedCrossRef
37.
go back to reference Van Meurs JB, Dhonukshe-Rutten RA, Pluijm SM, Van der Klift M, De Jonge R, Lindemans J, De Groot LC, Hofman A, Witteman JC, Van Leeuwen JP, Breteler MM, Lips P, Pols HA, Uitterlinden AG (2004) Homocysteine levels and the risk of osteoporotic fracture. N Engl J Med 350:2033–2041PubMedCrossRef Van Meurs JB, Dhonukshe-Rutten RA, Pluijm SM, Van der Klift M, De Jonge R, Lindemans J, De Groot LC, Hofman A, Witteman JC, Van Leeuwen JP, Breteler MM, Lips P, Pols HA, Uitterlinden AG (2004) Homocysteine levels and the risk of osteoporotic fracture. N Engl J Med 350:2033–2041PubMedCrossRef
38.
go back to reference Kuyumcu ME, Yesil Y, Ozturk ZA, Cinar E, Kizilarslanoglu C, Halil M, Ulger Z, Yesil NK, Cankurtaran M, Ariogul S (2012) The association between homocysteine (hcy) and serum natural antioxidants in elderly bone mineral densitometry (BMD). Arch Gerontol Geriatr 55:739–743PubMedCrossRef Kuyumcu ME, Yesil Y, Ozturk ZA, Cinar E, Kizilarslanoglu C, Halil M, Ulger Z, Yesil NK, Cankurtaran M, Ariogul S (2012) The association between homocysteine (hcy) and serum natural antioxidants in elderly bone mineral densitometry (BMD). Arch Gerontol Geriatr 55:739–743PubMedCrossRef
39.
41.
go back to reference Chen J, Chloupkova M, Gao J, Chapman-Arvedson TL, Enns CA (2007) HFE modulates transferrin receptor 2 levels in hepatoma cells via interactions that differ from transferrin receptor 1–HFE interactions. J Biol Chem 282:36862–36870PubMedCrossRef Chen J, Chloupkova M, Gao J, Chapman-Arvedson TL, Enns CA (2007) HFE modulates transferrin receptor 2 levels in hepatoma cells via interactions that differ from transferrin receptor 1–HFE interactions. J Biol Chem 282:36862–36870PubMedCrossRef
42.
go back to reference Goswami T, Andrews NC (2006) Hereditary hemochromatosis protein, HFE, interaction with transferrin receptor 2 suggests a molecular mechanism for mammalian iron sensing. J Biol Chem 281:28494–28498PubMedCrossRef Goswami T, Andrews NC (2006) Hereditary hemochromatosis protein, HFE, interaction with transferrin receptor 2 suggests a molecular mechanism for mammalian iron sensing. J Biol Chem 281:28494–28498PubMedCrossRef
Metadata
Title
Hepcidin1 Knockout Mice Display Defects in Bone Microarchitecture and Changes of Bone Formation Markers
Authors
Guang Si Shen
Qing Yang
Jing Long Jian
Guo Yang Zhao
Lu Lin Liu
Xiao Wang
Wen Zhang
Xi Huang
You Jia Xu
Publication date
01-06-2014
Publisher
Springer US
Published in
Calcified Tissue International / Issue 6/2014
Print ISSN: 0171-967X
Electronic ISSN: 1432-0827
DOI
https://doi.org/10.1007/s00223-014-9845-8

Other articles of this Issue 6/2014

Calcified Tissue International 6/2014 Go to the issue